Insulin (INS) synthesis and secretion from pancreatic b-cells are tightly regulated; their deregulation causes diabetes. Here we map INS-associated loci in human pancreatic islets by 4C and 3C techniques and show that the INS gene physically interacts with the SYT8 gene, located over 300 kb away. This interaction is elevated by glucose and accompanied by increases in SYT8 expression. Inactivation of the INS promoter by promoter-targeting siRNA reduces SYT8 gene expression. SYT8-INS interaction and SYT8 transcription are attenuated by CTCF depletion. Furthermore, SYT8 knockdown decreases insulin secretion in islets. These results reveal a nonredundant role for SYT8 in insulin secretion and indicate that the INS promoter acts from a distance to stimulate SYT8 transcription. This suggests a function for the INS promoter in coordinating insulin transcription and secretion through long-range regulation of SYT8 expression in human islets.
a r t i c l e s
The human genome is organized within the nucleus into a compact chromatin structure that facilitates many interactions between what are otherwise distal sites 1 . A few of these long-range interactions have been shown to affect gene transcription in human cells [2] [3] [4] [5] . However, the function of chromatin interactions in the regulation of physiological processes and the way that environmental signals regulate these dynamic interactions in human tissues remain to be determined. We investigated the INS gene locus in this study both for its physiological importance and as a model to study the role of long-range chromatin interactions in the establishment of regulatory networks. Most of our knowledge about insulin gene expression and regulation comes from studies done in rodents, especially mice. However, there are two insulin genes in rodents and only one in humans, and it has become apparent recently that human pancreatic islets have unique anatomical and functional features not shared with rodent islets [6] [7] [8] [9] . For these and other reasons, we made use of intact human pancreatic islets, in which the INS gene is active.
The human INS gene, located on chromosome 11p15, is flanked by two clusters of imprinted genes. The DNA sequence and gene organization of this 1-Mb gene-dense region are conserved between mouse and human 10 . Insulin transcription and secretion from pancreatic β-cells are tightly regulated in response to glucose 11, 12 . Glucose markedly stimulates the human INS promoter activity in transfected primary islet cells 13, 14 , actively promotes open chromatin structure and RNA polymerase II recruitment on the endogenous INS promoter, and increases INS gene transcription in human islets 11, 15, 16 . The INS gene is transcribed at high levels only in pancreatic β-cells 17, 18 . The mouse Ins2 gene and its human ortholog physically interact with the distal H19 imprinted control region (ICR) and enhancers that are located over 100 kb away [19] [20] [21] . The H19 ICR has been the subject of intense study, and recent circular chromosome conformation capture (4C) analyses have revealed its long-range interactions with other gene loci, affecting transcription of distant genes in at least two cases [22] [23] [24] . Although these data provide evidence for the existence of long-range physical contacts involving the INS gene, they are limited to the region near H19 in tissues or cells not expressing insulin.
In this study, we undertook a series of chromosome conformation capture (3C) and 4C studies 24, 25 in human islets to determine patterns of interaction between the INS gene and other sites within the nucleus and to explore possible connections with INS expression. We show that in human islets, the INS promoter physically interacts with and positively regulates transcription of the SYT8 gene located over 300 kb away and that this gene is a critical regulator of insulin secretion. These results suggest a regulatory function for the INS promoter in coupling insulin transcription with secretion through regulation of SYT8 gene expression in human islets.
RESULTS

4C-Seq analysis reveals SYT8-TNNI2 locus association with INS
Initial 3C studies confirmed that the INS gene and the H19 ICR interact with each other both in normal human primary fibroblasts (NHPF) and, at a higher level, in human islets ( Supplementary Fig. 1 ). We explored more generally, using the 4C method 24, 25 , interactions in human islets between the INS gene and other genomic sites. This procedure (4C-Seq, Supplementary Fig. 2a ) was done essentially as previously described 25 , except for the last few steps.
We first conducted 4C-Seq using a part of the INS promoter and gene body as the bait (see Supplementary Fig. 2b ). This generated a r t i c l e s 1.8 million unique sequence reads; 29.6% of them were mapped within the 1-Mb region surrounding the INS gene. In islets treated with glucose for 1 h, the INS gene interacted strongly with loci in this 1-Mb region ( Fig. 1a,b ). Multiple interacting sites were clustered in this region. The analysis was repeated with islets from another donor and using the other side of the BglII site as the bait ( Supplementary  Fig. 2b ); similar contact patterns were observed for this 1-Mb region (P < 10 −90 ) ( Supplementary Fig. 3a and Supplementary Notes). The 4C-Seq method is thus reproducible (see Supplementary Notes). Because we were focused on interactions within this 1-Mb locus, we did not attempt to comprehensively identify more distant regions on chromosome 11 or on any of the other chromosomes ( Fig. 1a and Supplementary Notes). Instead, we used the 4C data to provide partial information about strong long-range contacts that could then be confirmed and explored by 3C methods.
The INS-interacting loci in this 1-Mb region ( Fig. 1b) are in a part of the genome that is evolutionarily conserved in DNA sequence and gene organization 10 and contains genes that play roles in diverse cellular processes, including exocytosis, cellular proliferation and apoptosis, and cell-cell interactions. In this study we focus on one of these genes, SYT8 (encoding synaptotagmin 8) 26, 27 , and its immediate neighbor TNNI2. Other synaptotagmins have been shown to be Ca 2+ sensors for neurotransmitter release in neurons 28 , and they are thought to regulate insulin secretion in pancreatic β cells 26, 27, [29] [30] [31] . Syt8 could also be involved in this process because its C 2 AB domain peptide markedly decreases Ca 2+ -induced insulin secretion when introduced into primary rat islet cells 26 . However, earlier studies 27 of Syt8 concluded that it did not act as a calcium sensor in endocrine cells or neurons and did not participate in the calcium-mediated regulation of evoked exocytosis. Whether SYT8 plays a role in insulin secretion thus remains unclear.
Our analysis showed that the INS gene physically contacted both the promoter and 3′ downstream region of SYT8 (Fig. 1c) . The second INSinteracting site is located less than 2 kb away from the transcription start site of TNNI2, the neighboring gene of SYT8 (see Fig. 1c for the location). The INS gene did not interact with the CTSD gene or the 3′ downstream region of the LSP1 gene, two flanking genomic regions both located about 60 kb away from the SYT8-TNNI2 locus (Fig. 1c) ; this was confirmed in further 3C experiments (see below). Proximity alone is thus not sufficient for an interaction. Finally, 4C-Seq analysis showed that the INS gene did not interact with any of the other SYT gene family members, such as SYT7, SYT9 or SYT13, that are also located on chromosome 11 ( Fig. 1a, Supplementary Fig. 3b and data not shown).
3C analysis confirms SYT8-TNNI2 locus interaction with INS
To confirm the 4C results ( Fig. 1c) , we designed quantitative 3C experiments specifically to detect interactions between the INS bait and the region containing the SYT8 and TNNI2 genes in islets treated with glucose for 1 h. We focused on interactions of the INS gene with eight BglII sites in the region, representing the two sites at the SYT8 promoter and its 3′ downstream site (or the TNNI2 promoter), two immediately neighboring sites flanking the SYT8-TNNI2 locus, three sites covering the LSP1 gene and the only site within the CTSD gene (see Fig. 1c for the location). Quantitative 3C assays confirmed strong contacts between INS and the SYT8-TNNI2 locus in islets from a second donor ( Fig. 1d) . Weak contact between these sites occurred in human primary fibroblasts at one-half to one-third the levels seen in islets ( Fig. 1d) . Similar to the 4C-Seq analysis, this 3C assay also showed that the INS gene interacted strongly with the LSP1 gene but not with its 3′ downstream region or the CTSD gene in islets ( Fig. 1d) . Islets from the same donor were also used to generate islet-derived precursor cells (hIPC) that express the INS 32 or SYT8 gene weakly, if at all ( Supplementary Fig. 4a ). After islets were dedifferentiated into hIPC, INS interactions with the SYT8-TNNI2 locus were decreased to about one-third, whereas the LSP1-INS interaction in hIPCs, unlike those in fibroblasts, was maintained ( Fig. 1d) . This confirmed the 4C-Seq results showing that the SYT8-TNNI2 locus interacts with the INS gene in islets and suggested that these intranuclear interactions might be regulated, at least partly, by an islet cell-specific mechanism. We note that although INS makes strong contacts with SYT8-TNNI2, it does not make contact with the nearby CTSD gene ( Fig. 1d) , which is also active in islets (see below), indicating that the contacts are not generated simply through active transcription.
Glucose stimulates INS-SYT8 interactions and SYT8 expression
To determine whether glucose could regulate INS-SYT8 interaction in islets, we measured its effect on 3C contacts. Before glucose addition, a r t i c l e s interactions of SYT8 and its nearby region with INS were readily detected; half an hour after glucose addition, INS interactions with the SYT8 promoter and its 3′ downstream region (or the TNNI2 promoter) were increased by 3-to 5-fold in islets from two donors ( Fig. 2a) . The INS-CTSD interaction, by contrast, was weak both before and after glucose treatment ( Fig. 2a) . One hour after glucose treatment, a 1.8-to 3.2-fold increase in INS-SYT8 interaction was also seen in islets from three donors ( Fig. 2b) . Time-course analysis in one donor's islets showed that this interaction increased five fold within 30 min of glucose treatment and then gradually decreased ( Fig. 2c) .
We conclude that glucose dynamically regulates interactions of the SYT8-TNNI2 locus with INS in islets. Glucose markedly increases human INS promoter activity in primary cultured islet cells 13, 14 and also stimulates endogenous INS gene transcription in human islets 15, 16 . It has been reported that within 30 min of addition, glucose markedly increases histone H4 acetylation and RNA polymerase II recruitment to the INS promoter in islets 11, 15 , whereas the levels of mature INS transcripts appear to be stable for at least 48 h after glucose treatment; their long half-life leads to high levels of accumulation in β-cells 15, 16 . We confirmed this result: levels of mature INS transcript were stable ( Fig. 2d) . On the other hand, steady-state mRNA levels of SYT8 and TNNI2 were increased by 1.4-to 3.2-fold within 30 min of glucose treatment in islets from three donors ( Fig. 2d) . In contrast, SYT7 and SYT13 expression levels were almost unchanged ( Fig. 2d) . Glucose thus specifically and rapidly increases SYT8 and TNNI2 gene expression in islets, with kinetics of mRNA accumulation similar to the EGR1 (also called ZIF268) gene, whose expression is also regulated by glucose in pancreatic β-cells 33 (Supplementary Fig. 5 ). Therefore, SYT8 and TNNI2 increases in expression correlate in time with increases in INS interactions with the SYT8 and TNNI2 locus upon glucose treatment in islets.
The INS promoter positively regulates SYT8 and TNNI2 expression
The data presented so far are formally consistent with a model in which both INS and SYT8 expression are stimulated by glucose and, as a consequence, are drawn into proximity at a shared transcription factory, as shown for the globin locus 34, 35 . The data are also consistent with a distinct, but not incompatible, model in which insulin expression levels directly affect SYT8 expression. To investigate the role of the INS promoter in SYT8 and TNNI2 transcription, we treated islets with short interfering RNAs (siRNAs) that specifically target the INS promoter ( Fig. 3a) . Promoter-targeting siRNAs have been shown to inactivate endogenous promoters in dividing and nondividing human cells 36, 37 . Islets were treated with the INS promoter-targeting siRNA duplexes or control siRNA duplexes for 4.5 d. To prevent effects of the potential insulin deficiency in siRNA-treated islets on gene expression 38 , siRNA-treated islets were washed twice with fresh basal islet medium and cultured in fresh supplemented islet medium containing physiological levels a r t i c l e s of exogenous insulin for at least 6 h before total RNAs were prepared. Treatment of islets from two donors with these siRNAs led to 34-50% reduction in the INS preRNA levels (Fig. 3a,b) , indicative of effective silencing of the INS promoter. The steady-state INS mRNA levels were stable or slightly decreased after this short-term siRNA treatment ( Fig. 3a,b) , probably because of their long half-life. This siRNA-induced inactivation of the INS promoter decreased SYT8 and TNNI2 gene expression by 58-83% and 43-66%, respectively, in islets from two donors (Fig. 3a,b) . This inactivation did not, however, alter expression of SYT13 or of CTSD and MRPL23, two genes located about 60 and 100 kb away, respectively, from each end of the SYT8-TNNI2 locus. In addition, it had little effect on expression of KCNQ1 and TSSC4, which are also located in the 1-Mb region (Supplementary Fig. 6a ). These results demonstrate that the INS promoter exerts long-range effects on the regulation of SYT8 and TNNI2 gene transcription in islets. Although it is likely that INS, SYT8 and TNNI2 do share a transcription factory, this is not sufficient to explain the dependence of SYT8 expression on the INS promoter (see Discussion). The data also indicate that long-range regulation of transcription by the INS promoter is not domain wide but gene specific. Because inactivation of the INS promoter has no effect on expression of MRPL23, a gene located between the SYT8 and INS loci and about 100 kb closer to INS than SYT8 and TNNI2, the INS promoter seems to spread its effects on transcription not by linear propagation of an activating signal but more likely through higher-order chromatin organization [1] [2] [3] [4] [5] 20, 22, 24, 25 .
The mechanism by which the INS promoter transactivates SYT8 remains to be determined. However, we found that the INS promoter, when coupled to the SYT8 promoter, could stimulate SYT8 promoter activity (Supplementary Fig. 6b) . In a complementary experiment, inactivating the SYT8 promoter in islets had little effect on INS expression ( Supplementary Fig. 7) .
CTCF regulates SYT8 and TNNI2 expression and INS contacts
CTCF binds to DNA in a largely cell type-independent manner 39 and is a major regulator of chromatin architecture 20, 22, 24, 39 . The presence of CTCF-binding sites at both SYT8 and TNNI2 promoters and at the 3′ downstream region of the INS gene 40 (see Supplementary Fig. 8a,b for the location) suggests its involvement in the regulation of INS-SYT8 interaction. Incubation of islets with CTCF-specific siRNAs reduced CTCF gene expression from four donors by 40-72% (Fig. 4a) , whereas it caused a 46-76% decrease in SYT8 mRNA levels but had little effect on SYT7 and INS gene expression ( Fig. 4a) . Similarly to SYT8, TNNI2 gene expression was also reduced by CTCF knockdown in islets from three of four donors (Fig. 4a) . CTCF depletion reduced SYT8-INS interaction in the same islets described above ( Fig. 4b and Supplementary  Fig. 8c ). The decrease in SYT8-INS interaction and SYT8 gene expression is correlated with the extent of CTCF knockdown (Fig. 4a,b) , indicating that CTCF is important for maintenance of SYT8-INS interaction as well as SYT8 and TNNI2 gene expression in islets. The INS-SYT8 interaction is also detected, although at much lower levels ( Fig. 1d and Supplementary Fig. 4c ), in human primary fibroblasts that do not express SYT8 and TNNI2 genes at appreciable levels (Supplementary Fig. 4b) . CTCF depletion in fibroblasts reduced CTCF binding at the SYT8 and INS loci and caused a 67% Figure 5 SYT8 is an important regulator of insulin secretion in human islets. (a) qRT-PCR analysis of SYT8 gene expression in islets treated with control (white bar) or SYT8-specific siRNA (black bar). Total RNA was prepared directly from siRNA-treated islets without medium change. The mean ± s.e.m. is shown (n = 9). (b) ELISA analysis of insulin levels in the medium for islets from five donors that were separately treated with siRNA as in a.
The insulin levels are normalized to the amount of total RNAs made from the treated islets. As insulin levels vary among islets from different donors, the insulin levels relative to control are plotted. The mean ± s.e.m. is shown (n = 20, four measures for each of five donors); ***P < 0.0001. (c) ELISA analysis of insulin levels in the medium of islets from one donor treated as in b and cultured with 30.5 mM glucose for 30 min. The insulin levels are normalized to the amount of islets necessary to produce 1 µg total RNA; ***P < 0.0001. (d) ELISA analysis of insulin levels in the medium of islets from another donor that were treated as in c and cultured with 30.5 mM glucose or 20 mM l-arginine for 30 min. The insulin levels are normalized as in c. ***P < 0.0001; *P = 0.0018. (e) Insulin secretion from siRNA-treated islets that were treated with 30.5 mM glucose; supernatants were collected every 5 min and tested. The mean ± s.d. is shown for c and e (n = 4). Glucose Arginine Insulin levels (µIU ml -1 ) d a r t i c l e s reduction in the SYT8-INS interaction (Fig. 4c-e ), suggesting that CTCF binding at the SYT8 and INS loci also regulates long-range SYT8-INS interactions in human fibroblasts.
SYT8 is an important regulator of insulin secretion in islets
The existence of an actively regulated mechanism for SYT8 gene expression ( Figs. 2 and 3) and its potential involvement in insulin secretion 26 suggest that SYT8 has a role in controlling glucose response in islets. Incubation of islets with an SYT8-specific siRNA caused a 77% reduction in SYT8 gene expression ( Fig. 5a) . Compared to islets treated with control siRNA, basal insulin secretion from SYT8-depleted human islets was decreased on average by 43% (P < 0.0001) (Fig. 5b) . SYT8 knockdown in islets from two donors also attenuated glucose-and arginine-induced insulin secretion by more than 50% (P < 0.0001) ( Fig. 5c,d ) and 31% (P = 0.0018) ( Fig. 5d) , respectively. Finally, SYT8 depletion impaired the first and second phase of insulin secretion in an insulin secretion assay (Fig. 5e ). We conclude that, similar to Syt7 in mice 30 , the SYT8 gene is important for both basal and glucose-stimulated insulin secretion in human islets. Consistent with this finding, the mouse Syt8 gene is important for exocytosis of acrosomes in sperm 41 .
DISCUSSION
An important role for the INS promoter in long-range transcriptional regulation was evident from our observations that specific inhibition of INS transcription by promoter-targeting siRNA decreases SYT8 and TNNI2 gene expression by 40-80% in human islets. SYT8 and TNNI2 gene expression correlate positively with their interactions with the INS gene in islets treated with glucose ( Fig. 2) , indicating a positive role for intranuclear contact between the INS gene and the SYT8-TNNI2 locus in SYT8 and TNNI2 gene transcription. Glucose stimulates both INS promoter activity in primary islet cells 13, 14 and interactions of the INS gene with the SYT8-TNNI2 locus in islets (Fig. 2) , compatible with the notion that glucose could enhance SYT8 and TNNI2 gene expression through increasing their interactions with INS. Our current study reveals a mechanism by which a strong tissue-or cell type-specific regulatory element can coordinate cellular response to acute environmental and developmental signals through remote control of transcription of a second broadly expressed gene.
Our work indicates that CTCF is important for maintenance of interactions of INS with SYT8 and TNNI2 and for SYT8 and TNNI2 expression in islets. Because CTCF depletion had little effect on INS gene expression in human islets (Fig. 4a) , CTCF probably does not act by directly activating transcription but more likely does so through regulating long-range chromosomal interactions, as previously shown in the β-globin and H19 loci 20, 22, 24, 25 . The observations that SYT8-INS interactions and SYT8 gene expression are markedly reduced upon CTCF depletion and that CTCF-binding sites are present in both INS and SYT8 loci suggest that CTCF-dependent SYT8-INS interactions positively regulate SYT8 and TNNI2 gene transcription in islets. CTCF may be involved in many cell types in organizing local chromatin architecture that could poise the SYT8 and TNNI2 genes for enhanced transcriptional activation once a cell type-specific activating signal is available (see model in Supplementary Fig. 9 ). Because of technical limitations in using human tissues and potential indirect effects of CTCF knockdown, we can only demonstrate a correlation between CTCF-mediated stabilization of long-range contacts and effects on SYT8 and TNNI2 expression. Given the complex nature of networks stabilized by CTCF interactions, it is in any case difficult to isolate the effects of a single interacting pair of sites.
Interactions of the SYT8-TNNI2 locus with the INS gene may potentially promote SYT8 and TNNI2 gene transcription by recruiting active histone marks present on the INS promoter to the SYT8 and TNNI2 promoters 15, 32, 42 , or by allowing transcription factors bound to the INS promoter to directly activate SYT8 expression in a manner analogous to transvection in Drosophila. We considered whether these effects could have arisen solely from independent recruitment of both INS and SYT8 promoters to a center of high RNA polymerase II concentration 34, 35 . It is likely that these genes, when expressed, do share such a transcription factory. However, this is not sufficient to explain our observation that inactivation of the INS promoter reduces SYT8 and TNNI2 expression as well as INS gene transcription. It also isn't sufficient to explain our finding that INS expression is not affected by loss of CTCF binding and the SYT8-INS interaction, whereas SYT8 and TNNI2 expression are markedly decreased. Previously reported properties of transcription factories do not include the ability of some genes present within a factory to transactivate others in the same factory. In the case of the INS locus, it appears that CTCF has a role in facilitating the INS-SYT8 or INS-TNNI2 interaction, and this interaction is coupled with an activation of SYT8 or TNNI2 expression that is dependent on the level of INS expression. Finally, as impaired insulin secretion and diabetes have been observed in an individual with a balanced chromosomal translocation t(1;11)(p36.22;p15.5) that causes physical separation of the INS gene from SYT8 and other nearby genes 43 , local genomic organization around INS might contribute to regulation of islet function.
An important role for SYT8 in insulin secretion, identified here, is unexpected because SYT8 lacks the critical aspartate residues for Ca 2+ binding at both C 2 domains and cannot bind phospholipids and target membrane SNARE (soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor) 44 . In contrast to Syt7 and Syt9, Syt8 fails to stimulate in vitro SNARE-mediated membrane fusion 44 , an essential step for exocytosis of insulin. On the other hand, SYT8 has been shown to bind syntaxins with an affinity similar to or higher than Syt1 45 , to regulate in vitro Syt1-stimulated membrane fusion 44 and to interact with Syt7 in a Ca 2+ -dependent manner, although the interaction is weak and likely transient and hard to detect in cells 46 . These studies suggest that SYT8 may serve as a regulatory protein for other SYTs. The exact steps at which SYT8 acts during insulin secretion are unclear.
Our work reveals that through regulation of SYT8, the INS promoter may couple INS gene transcription with insulin secretion in islets. It seems advantageous that SYT8 gene transcription could be quickly adjusted in response to glucose through the INS promoter so that the cytosolic SYT8 pool in β-cells could be refilled for the next round of insulin secretion. This new mechanism for co-regulation is distinct from-and more direct than-the feedback regulatory effects of secreted insulin on β-cells 38, 47 . Together with the finding that secreted insulin stimulates INS gene transcription 38, 47 , our data reveal a positive feedback circuit that functions in islets to coordinate insulin transcription and secretion. This regulatory circuit might be important for robust and timely secretion of insulin in response to rapid changes of glucose concentrations. Furthermore, severe reduction in insulin transcription could potentially disrupt the regulatory circuit and lead to deregulation of insulin secretion. This may be relevant to pathogenesis of human diabetes: inactivating mutations in the INS promoter regulator genes PDX1, HNF1A, HNF1B, HNF4A and NEUROD1 (refs. 48-50) cause impaired insulin secretion in patients with monogenic forms of diabetes, such as maturity-onset diabetes of the young (MODY) 51 , and loss-of-function mutations in the human INS promoter region cause neonatal diabetes 52 . a r t i c l e s Coordinated regulation of transcription by the INS promoter may not be limited to SYT8. Steady-state TNNI2 expression is similarly regulated in islets. This suggests that glucose-regulated INS promoter activity may coordinate multiple β-cell functions. Because TNNI2 interacts with and activates the transcriptional activity of estrogen receptor-related receptor α (ref. 53) , an important regulator of energy metabolism 54, 55 , regulation of TNNI2 gene transcription by the INS promoter might contribute to this function in human islets. Remote regulatory control by the INS promoter may have implications for the pathology and treatment of type 2 diabetes. The United Kingdom Prospective Diabetes Study clinical trials have shown the critical role of preserving β-cell functions for the management of type 2 diabetes 56 . Our work suggests that recovering and sustaining active transcriptional activity on the INS promoter could constitute an important target to achieve this.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
